<?xml version="1.0" encoding="UTF-8"?>
<div class="fig" id="PMC7916715/figure_2" xmlns="http://www.w3.org/1999/xhtml">
 <caption> Enrichment of CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 gene set in LNCaP CNTN1 cells. ( A) Gene set enrichment analysis (GSEA) analysis reveals the enrichment of CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 gene set in the differentially expressed genes (DEGs) relative to CNTN1 overexpression (LNCaP CNTN1 vs. LNCaP EV). The leading-edge genes ( n = 10) in this enrichment are indicated (see Table 1 for individual leading-edge genes). ( B) Confirmation of the upregulations of 7 of 10 leading-edge genes in LNCaP CNTN1 cells. ( C) Confirmation of CNTN1 overexpression in LNCaP CNTN1 cells. * p &lt; 0.05, ** p &lt; 0.01, *** p &lt; 0.001, **** p &lt; 0.0001. </caption>
 <div class="graphic"/>
 <p class="label">Figure 2</p>
</div>
